Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | DFP-14927 |
Synonyms | |
Therapy Description |
DFP-14927 is a pegylated version of DFP-10917, which is a deoxycytidine analogue that gets incorporated into DNA and inhibits DNA replication, potentially resulting in increased cell cycle arrest and apoptosis in tumor cells (NCI Drug Dictionary). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
DFP-14927 | DFP14927|DFP 14927|PEGylated DFP-10917 | DFP-14927 is a pegylated version of DFP-10917, which is a deoxycytidine analogue that gets incorporated into DNA and inhibits DNA replication, potentially resulting in increased cell cycle arrest and apoptosis in tumor cells (NCI Drug Dictionary). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT03943004 | Phase I | DFP-14927 | Trial of DFP-14927 in Advanced Solid Tumors | Recruiting | USA | 0 |